Patents Assigned to Atlanta Pharma AG
  • Publication number: 20090087871
    Abstract: The invention relates to a novel polypeptide containing the GAFA-domain and GAFB-domain of a human phosphodiesterase 5 (PDE5) and the catalytic domain of an adenylate cyclase, and to the use of this polypeptide in a method for identifying PDE5-modulators.
    Type: Application
    Filed: May 18, 2005
    Publication date: April 2, 2009
    Applicant: Atlanta Pharma AG
    Inventors: Tobias Kanacher, Juergen Linder, Joachim Schultz
  • Publication number: 20090011978
    Abstract: The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions.
    Type: Application
    Filed: August 27, 2004
    Publication date: January 8, 2009
    Applicant: Atlanta Pharma AG
    Inventors: Dietrich Hafner, Ralf Harand, Eva Ammon, Ernst Sturm, Klaus Eistetter, Friedemann Taut, Thomas Muller
  • Publication number: 20070219236
    Abstract: The invention relates to compounds of formula 1 and to medicaments comprising these compounds.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 20, 2007
    Applicant: Atlanta Pharma AG
    Inventor: Wilm Buhr
  • Publication number: 20070208034
    Abstract: The invention relates to novel pyrimidine derivatives of Formula (1) which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.
    Type: Application
    Filed: June 28, 2005
    Publication date: September 6, 2007
    Applicant: Atlanta Pharma AG
    Inventor: Josef Stadlwieser
  • Publication number: 20070191413
    Abstract: Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Application
    Filed: March 3, 2005
    Publication date: August 16, 2007
    Applicant: Atlanta Pharma AG
    Inventor: Ulrich Kautz
  • Publication number: 20070179146
    Abstract: The compounds of a certain formula 1, in which R1, R2, R3 and R9 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: February 1, 2005
    Publication date: August 2, 2007
    Applicant: Atlanta Pharma AG
    Inventors: Wiro Menge, Geert Sterk
  • Publication number: 20060235053
    Abstract: The invention relates to the use of pantoprazole in the treatment of lower abdominal disorders.
    Type: Application
    Filed: May 4, 2004
    Publication date: October 19, 2006
    Applicant: Atlanta Pharma AG
    Inventors: Ursula Gebauer, Iris Velten, Wolfgang-Alexander Simon
  • Publication number: 20060142308
    Abstract: The invention relates to the combined administration of roflumilast and formoterol for the treatment of respiratory tract disorders.
    Type: Application
    Filed: November 26, 2003
    Publication date: June 29, 2006
    Applicant: Atlanta Pharma AG
    Inventors: Norbert Kolassa, Christian Weimar, Daniela Bundschuh, Rolf Beume, Degenhard Marx
  • Publication number: 20060035892
    Abstract: The invention relates to nitrosated imidazopyridines of a certain formula (I), in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting, anti-inflammatory and antibacterial properties.
    Type: Application
    Filed: April 22, 2003
    Publication date: February 16, 2006
    Applicant: Atlanta Pharma AG
    Inventors: Wilm Buhr, Jorg Senn-Bilfinger, Peter Zimmermann
  • Publication number: 20050131026
    Abstract: The invention relates to the use of proton pump inhibitors in the treatment of airway disorders.
    Type: Application
    Filed: March 11, 2003
    Publication date: June 16, 2005
    Applicant: Atlanta Pharma AG
    Inventor: Wolfgang-Alexander Simon
  • Patent number: 6696460
    Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: February 24, 2004
    Assignee: Atlanta Pharma AG
    Inventor: Jörg Senn-Bilfinger